close
close Close

Latest on Twitter

Smart Branding
menu
Akamis Bio
PsiOxus Therapeutics Transforms Into Akamis Bio With $30 Million Investment

PsiOxus Therapeutics is a clinical-stage oncology company that is dedicated to improving the lives of individuals living with cancer through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform.

Previous page Next page